Science Explorer Back to mapMap
Discussion
Researcher · Cubist Pharmaceuticals (United States) · United States

Philippe Prokocimer

Philippe Prokocimer publishes mostly in Infectious Diseases, Pharmacology and Clinical Biochemistry, on topics such as Antimicrobial Resistance in Staphylococcus, Antibiotics Pharmacokinetics and Efficacy and Bacterial Identification and Susceptibility Testing.

OpenAlex
World rank
#758,484
of 7,710,434 ranked researchers
Rank in United States
#254,470
of 1,627,098
Works
91
Citations
3.5k
Citations per work
38.7
h-index
29
i10-index 52Top 11% in Infectious Diseases
Philippe Prokocimer

What does Philippe Prokocimer research?

Philippe Prokocimer's work is mostly in Medicine (42%), Biochemistry, Genetics and Molecular Biology (11%).

Everything else: 43 works · 47.0% of their workHealth Sciences: 39 works · 42.4% of their workMedicine: 39 works · 42.4% of their workInfectious Diseases: 20 works · 22.3% of their workPharmacology: 8 works · 8.7% of their workEpidemiology: 6 works · 6.1% of their workSurgery: 5 works · 5.3% of their workLife Sciences: 10 works · 10.6% of their workBiochemistry, Genetics and Molecular Biology: 10 works · 10.6% of their workClinical Biochemistry: 6 works · 6.8% of their workMolecular Biology: 3 works · 3.8% of their workTHEIR WORKPhilippeProkocimer91works
Life Sciences11%Health Sciences42%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
  1. Everything else4347.0%
    1. Medicine3942.4%
    1. Biochemistry, Genetics and Molecular Biology1010.6%
  1. 1Infectious Diseases22% of their works
  2. 2Pharmacology9% of their works
  3. 3Clinical Biochemistry7% of their works
  4. 4Epidemiology6% of their works
  5. 5Surgery5% of their works
  6. 6Molecular Biology4% of their works

Research topics

Which keywords describe Philippe Prokocimer's research?

The keywords of their largest research topics: Antimicrobial Resistance, Epidemiology, Virulence Factors, MRSA, Staphylococcus aureus, Antibiotic Pharmacokinetics, Critically Ill Patients and Antibiotic Resistance.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 21 words, with their numbers
  1. Antimicrobial Resistance612 topics
  2. Epidemiology604 topics
  3. Virulence Factors502 topics
  4. MRSA421 topic
  5. Staphylococcus aureus421 topic
  6. Antibiotic Pharmacokinetics191 topic
  7. Critically Ill Patients191 topic
  8. Antibiotic Resistance173 topics
  9. Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry171 topic
  10. Microorganism Identification171 topic
  11. ESKAPE Pathogens91 topic
  12. Multidrug-Resistant Bacteria91 topic
  13. Infectious Diseases82 topics
  14. Necrotizing Fasciitis81 topic
  15. Streptococcus Pyogenes81 topic
  16. Candidiasis61 topic
  17. Invasive Fungal Infections61 topic
  18. Antimicrobial Stewardship41 topic
  19. Bacteria41 topic
  20. Biofilms41 topic
  21. Global Health41 topic

Where does Philippe Prokocimer work?

Philippe Prokocimer's main affiliation in the publication record is Cubist Pharmaceuticals (United States), United States.

How many publications and citations does Philippe Prokocimer have?

OpenAlex counts 91 works and 3,525 citations for Philippe Prokocimer, an h-index of 29, ranking #758,484 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Philippe Prokocimer. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.